🔎 Trials Near Me

Akèy › Maladi sèvo › Michigan

Etid klinik pou Maladi sèvo nan Michigan

4 etid pou Maladi sèvo ap chèche patisipan nan sit nan Michigan.

Tèks ofisyèl etid la (Anglè)

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

  • QUEST Research Institute, Farmington Hills
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

  • Vima Site #002, Farmington Hills
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07804615

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • Henry Ford Hospital, Detroit
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT05386108

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  • Clinical Site, Ann Arbor
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 1, 2026 · NCT07459647

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.